Pregled bibliografske jedinice broj: 875370
Macrolide Hybrid Compounds: Drug Discovery Opportunities in Anti- Infective and Anti-inflammatory Area
Macrolide Hybrid Compounds: Drug Discovery Opportunities in Anti- Infective and Anti-inflammatory Area // Current topics in medicinal chemistry, 17 (2017), 8; 919-940 doi:10.2174/1568026616666160927160036 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 875370 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Macrolide Hybrid Compounds: Drug Discovery Opportunities in Anti- Infective and Anti-inflammatory Area
Autori
Čipčić Paljetak, Hana ; Tomašković, Linda ; Matijašić, Mario ; Bukvić, Mirjana ; Fajdetić, Andrea ; Verbanac, Donatella ; Perić, Mihaela
Izvornik
Current topics in medicinal chemistry (1568-0266) 17
(2017), 8;
919-940
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
macrolide hybrid, azalide, antibacterial, antimalarial, anti-inflammatory, quinolone, quinoline, corticosteroid
Sažetak
Macrolides, polyketide natural products, and their 15-membered semi-synthetic derivatives are composed of substituted macrocyclic lactone ring and used primarily as potent antibiotics. Recently their usefulness was extended to antimalarial and anti-inflammatory area. Hybrid macrolides presented in this article are the next generation semi-synthetic compounds that combine pharmacophores from antibacterial, antimalarial and anti-inflammatory area with 14- and 15-membered azalide scaffolds. Antibacterial azalide hybrids with sulphonamides showed improved activity against resistant streptococci while quinolone conjugates demonstrated full coverage of respiratory pathogens including macrolide resistant strains and their efficacy was confirmed in mouse pneumonia model. Antimalarial macrolide hybrids, mainly involving (chloro)quinoline pharmacophores, showed outstanding activity against chloroquine resistant strains, favourable pharmacokinetics, promising in vivo efficacy as well as encouraging developmental potential. Anti-inflammatory hybrids were obtained by combining macrolides with corticosteroid and non-steroidal anti-inflammatory drugs. They were found active in in vivo animal models of locally induced inflammation, asthma, inflammatory bowel disease and rheumatoid arthritis and demonstrated improved safety over parent steroid drugs. Overall, macrolide hybrids possess significant potential to be developed as potent novel medicines in therapeutic areas of utmost pharmaceutical interest.
Izvorni jezik
Engleski
Znanstvena područja
Temeljne medicinske znanosti
POVEZANOST RADA
Projekti:
HRZZ-IP-5467
Ustanove:
Medicinski fakultet, Zagreb,
PLIVA HRVATSKA d.o.o.,
Fidelta d.o.o.
Profili:
Mihaela Perić
(autor)
Mario Matijašić
(autor)
Donatella Verbanac
(autor)
Hana Čipčić Paljetak
(autor)
Linda Tomašković
(autor)
Andrea Fajdetić
(autor)
Mirjana Bukvić
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE